Lecture 21 /22 - Transplantaiton Immunology Flashcards

1
Q

Define the terms autograft, isograft, allograft, and xenografts.

L21 S5

A

Autograft:
-graft from one part of an individual to another part of the same individual

Isograft:
-graft from one individual to another genetically identical individual (between twins)

Allograft:
-graft from one individual to another, non-genetically identical individual

Xenograft:
-graft between members of different species

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What HLA classes are important to consider for transplantation?

L28 S7

A

Class I HLA:

  • HLA-A
  • HLA-B

Class II HLA:

  • HLA-DP
  • HLA-DQ
  • HLA-DR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Differentiate between direct and indirect allorecognition.

L21 S11-12

A

Direct:
-MHC of donor cells recognized by and activates recipient T cells

Indirect:

  • Ag of donor is processed by recipient APCs and recognized by recipient T cells
  • important in chronic rejection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the types of rejection and what is the timing of the reaction?

L21 S13

A

Hyperacute:

  • occurs in minutes to hours
  • caused by preformed antidonor Abs and complement

Accelerated:

  • occurs in days
  • reactivating of sensitized T cells

Acute:

  • occurs in weeks to day
  • primary activation of T cells

Chronic:

  • occurs in weeks to years
  • results form immunologic and non-immunologic factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the process of hyperacute graft rejection?

L21 S14

A

Caused by pre-existing Abs in the blood that are reactive to donor Ags

Examples:

  • ABO incompatibility
  • sensitization to donor MHC (due to repeated previous transplants/transfusions or pregnancy)

Results in complement activation and death of donor endothelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the process of acute graft rejection?

L21 S15

A

Caused by primary activation of T cells (CD4+ or CD8+)

Direct or indirect pathway

Donor DCs can move to lymph nodes where they initiate a primary immune response

or

Recipient CD8+ cells can recognize class I MHC of donor cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the process of chronic graft rejection?

L21 S16

A

Recipient immune system believes donor MHC is a self MHC carrying Ag. Results in occlusion of blood vessels and ischemia of donor organ.

Indirect pathway

Can also be caused by Ab mediated deposition of complement in donor organ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What non-immunologic factors must be considered for an transplant?

L21 S21

A

Mechanical trauma to graft tissue and ischemia-repercussion injury.

When transplanted, damaged grafts release clotting factors such as fibrin and fibrinopeptides which serve as chemoattractants to Mφ and neutrophils.

Also bradykinin is released increasing vascular permeability and vasodilation.

These events can lead to rejection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What workup must be done prior to transplantation?

L21 S22

A
  • determining ABO compatibility
  • identification of class I HLAs
  • crossmatching to test for preformed Abs against donor HLA
  • identification of class II HLA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What transplantation are ABO matching not important for?

L21 S23

A
  • cornea
  • heart valve
  • bone/tendon graft
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How is class I HLA typing achieved?

L21 S31

A

Certain individual are immunized against HLA Ags to produce anti-HLA Ab.

Anti-HLA Ab are introduced to sample containing lymphocytes.

If Ab binds Ag, classical complement pathway will be activated and lymphocyte will be lysed which is detected with staining methods.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is cross matching achieved and what is the purpose?

L21 S35

A

Tests for preformed Abs against donor HLA

Recipient serum is introduced to donor cells to test for preformed Abs against donor cells (microcytotoxicity test).

If Abs are present cell damage will occur (via complement MAC) and is indicated by dye absorption by cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is class II HLA typing achieved?

L21 S39

A

Lymphocytes of donor are irradiated to prevent proliferation to produce stimulator cells.

Stimulator cells present donor MHC Ags to recipient lymphocytes (responder cells).

Responder cells will be activated and proliferate when exposed to stimulator class II MHC that are not the same.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the characteristics of host versus graft and what are its effector mechanisms?

L21 S43-44

A

Stronger than response against pathogens (significantly more T cells are responsive to allogenic APCs than pathogens)

Has immune memory; second graft will be rejected more rapidly

Mechanisms:

  • humoral via Th2 (IL-4, 5, and 10)
  • cellular via Th1 (Il-2 and IFN-γ)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the characteristics of graft versus host and what are its effector mechanisms?

L21 S46

A

Occurs in transplants of small bowel, lung, or liver (due to native donor T cells)

Occurs in immunocomprimised recipients (due to inability to reject allogenic cells)

Mechanism:
-stimulation of recipient cell apoptosis by donor CTL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How are corticosteroids used as immunosuppressive drugs and what is the mechanism?
In what situation is it used?

L22 S31-32

A

Action:

  • inhibition of T cell proliferation
  • inhibition of pro-inflammatory genes (NF-κB pathway)
  • apoptosis of immune cells
  • activation/transcription of IL-10

Use:
-treatment of transplant rejection

17
Q

How is OKT3 used as immunosuppressive drugs?
In what situation is it used?

L22 S33-34

A

Anti-CD3 mouse IgG mAb

Action:
-blocks CD3 function and therefore helper T-cell function

Mechanims:

  • coating of T cell
  • depletion
  • down-modulation

Use:

  • acute/steroid resistant rejection
  • prophylactic treatment of solid organ transplants
18
Q

How is CsA used as immunosuppressive drugs?
In what situation is it used?

L22 S35-36

A

Fungal peptide

Action:

  • inactivates calcium dependent T-cell pathway by complexing with calmodulin (inhibits NFAT pathway)
  • inhibits Il-2, IL-3, IL-4, IL-5, IFN-γ, TNF-α, and GM-CSF

Use:
-prophylaxis in all organ transplants

19
Q

How is tacrolimus used as immunosuppressive drugs?
In what situation is it used?

L22 S37-38

A

Macrolide lactone from Streptomyces spp.

Action:

  • inhibits calcium dependent T-cell pathway by complexing with calmodulin (inhibits NFAT pathway)
  • inhibits Il-2, IL-3, IL-4, IL-5, IFN-γ, TNF-α, and GM-CSF

Use:
-prophylaxis in all organ transplants